Trial Profile
A prospective study to evaluate the efficacy and tolerability of Perampanel as an adjunctive treatment in children with severe epileptic encephalopathies
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Feb 2016
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Dravet syndrome; Epilepsy; Lennox-Gastaut syndrome
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2016 New trial record